Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.

Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of six hospitals and related operations in California consistent with previously disclosed terms. Tenet completed the sale of its four Orange County and Los Angeles County hospitals and related operations to UCI Health – consistent with the approval of the University of California Board of Regents. The completed transaction includes Fountain Valley Regional Hospital, Lakewood Regiona.

Tenet Completes Sale of Six Hospitals in California

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2024 results on Tuesday, April 30, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healt.

Tenet to Report its First Quarter 2024 Results on April 30th

In the most recent trading session, Tenet Healthcare (THC) closed at $102.05, indicating a -1.12% shift from the previous trading day.

Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note

Tenet Healthcare (THC) closed the most recent trading day at $100.38, moving +0.42% from the previous trading session.

Tenet Healthcare (THC) Increases Despite Market Slip: Here's What You Need to Know

Tenet Healthcare (THC) closed the most recent trading day at $95.56, moving +1.99% from the previous trading session.

Why the Market Dipped But Tenet Healthcare (THC) Gained Today

HCA Healthcare

Universal Health Services

Following a careful analysis of the Zacks Medical-Hospital industry, we advise focusing on companies like HCA, UHS and THC.

3 Stocks Worth a Deeper Dive in the Thriving Hospital Industry

Tenet Healthcare (THC) enters an agreement with Adventist Health to divest two of THC's hospitals, and continue to make Conifer's revenue cycle management services available for the divested operations.

Tenet Healthcare (THC) to Sell Hospitals to Refine Portfolio

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Adventist Health for the sale of two Tenet hospitals and related operations in San Luis Obispo County. Tenet also announced its Conifer Health Solutions subsidiary will enter into an agreement to provide revenue cycle services for Adventist Health. The transaction will include Sierra Vista Regional Medical Center and Twin Cities Community Hospital, as well as affiliated physician pract.

Tenet to Sell Two Hospitals and Enter into a Revenue Cycle Services Partnership with Adventist Health

Tenet Healthcare (THC) concluded the recent trading session at $89.22, signifying a -1.12% move from its prior day's close.

Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays Global Healthcare Conference on Tuesday, March 12, 2024, beginning at 9:30 a.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services co.

Tenet to Participate in Barclays 26th Annual Global Healthcare Conference

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of all $2,100 million outstanding of its 4.875% Senior Secured First Lien Notes due 2026 (the “Notes”), which were issued pursuant to the Indenture, dated as of November 6, 2001 (the “Base Indenture”), by and between Tenet and The Bank of New York, as predecessor to The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the Thirty-Second Supplemental Indenture, dated as of.

Tenet Calls for Full Redemption of 4.875% Senior Secured First Lien Notes due 2026

Tenet Healthcare Corporation (THC) Q4 2023 Earnings Call Transcript

Tenet Healthcare (THC) expects net operating revenues to be between $19.9 billion and $20.3 billion in 2024.

Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations

Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics

Tenet Healthcare Corp on Thursday forecast its annual profit above estimates after posting strong quarterly results, driven by higher admissions on the back of continued demand for non-urgent procedures in older adults.

Tenet Healthcare expects full-year profit above estimates on higher admissions

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter and year ended December 31, 2023. "Our businesses performed exceptionally well in 2023, driven by strong same facility revenue growth and disciplined operating management," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We carry momentum into 2024 and are focused on continuing to expand access to care and investing in cutting edge technology for our pat.

Tenet Reports Fourth Quarter and FY 2023 Results; Provides 2024 Financial Outlook

Tenet's (THC) fourth-quarter results are likely to reflect higher Ambulatory Care operating revenues and supply costs.

Can Tenet's (THC) Q4 Earnings Beat on Rising Patient Admissions?

Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Gear Up for Tenet (THC) Q4 Earnings: Wall Street Estimates for Key Metrics

Tenet (THC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Strength Seen in Tenet (THC): Can Its 7.7% Jump Turn into More Strength?

Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Should You Buy?

Acquisition of Tenet's Pacific Coast Network would expand unrestricted to healthcare for Orange County and beyond ORANGE, Calif. , Feb. 1, 2024 /PRNewswire/ -- The Regents of the University of California, on behalf of the University of California, Irvine, has entered into a definitive agreement with Tenet Healthcare Corporation (NYSE: THC) to acquire Tenet's Pacific Coast Network.

UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of three of its hospitals and related operations in South Carolina to Novant Health for approximately $2.4 billion. Tenet also announced it has entered into a definitive agreement with UCI Health for the sale of four Tenet hospitals and related operations in Orange County and Los Angeles County, California for approximately $975 million in cash. In addition, Tenet announced that it e.

Tenet Advances Portfolio Transformation and Previews Strong 2023 Results

In the latest trading session, Tenet Healthcare (THC) closed at $79.36, marking a +0.04% move from the previous day.

Tenet Healthcare (THC) Rises As Market Takes a Dip: Key Facts

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter 2023 results on Thursday, February 8, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified h.

News for Tenet Healthcare Stock (THC)